首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Oncolytic adenovirus-mediated MDA-7/IL-24 overexpressionenhancesantitumoractivityin hepatocellularcarcinomacelllines
【24h】

Oncolytic adenovirus-mediated MDA-7/IL-24 overexpressionenhancesantitumoractivityin hepatocellularcarcinomacelllines

机译:溶瘤腺病毒介导的MDA-7 / IL-24的过度表达增强肝癌细胞系的抗肿瘤活性

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Melanoma differentiation-associated gene-7 (MDA-7)/interleukin-24 (IL-24) is a novel tumor suppressor gene, which has suppressor activity in a broad spectrum of human cancer cells. We investigated the effect of the replication-competent oncolytic adenovirus SG600-IL24 and replication-incompetent adenovirus Ad.IL-24, both expressing human MDA-7/IL-24 on the hepatocellular carcinoma cell lines HepG2, Hep3B, SMMC-7721, HCCLM3, and the normal liver cell line L02. METHODS: Hepatocellular carcinoma cell lines and the normal liver cell line were infected with SG600-IL24 and Ad.IL-24. The mRNA and protein expression of MDA-7/IL-24 in infected cells was conifrmed by RT-PCR, ELISA, and Western blotting. MTT assay was used to investigate the proliferation effect. Hoechst staining and Annexin-V and PI staining were performed to study the MDA-7/IL-24 gene expressed in HCC cell lines and the normal liver cell line. Flow cytometry was used to analyse the cell cycle. RESULTS: RT-PCR, ELISA and Western blotting conifrmed that the exogenous MDA-7/IL-24 gene was highly expressed in cells infected with SG600-IL24. MTT and apoptosis detection indicated that SG600-IL24 induced growth suppression, promoted apoptosis, and blocked cancer cell lines in the G2/M phase in hepatocellular carcinoma cell lines but not in the normal liver cell line. CONCLUSIONS: SG600-IL24 selectively induces growth suppression and apoptosis in hepatocellular carcinoma cell lines in vitro but not in the normal liver cell line L02. Compared with Ad.IL-24, SG600-IL24 dramatically enhances antitumor activity in hepatocellular carcinoma cell lines.
机译:背景:黑色素瘤分化相关基因7(MDA-7)/白介素24(IL-24)是一种新型的抑癌基因,在广泛的人类癌细胞中具有抑癌活性。我们研究了具有复制能力的溶瘤腺病毒SG600-IL24和具有复制能力的腺病毒Ad.IL-24对肝癌细胞HepG2,Hep3B,SMMC-7721,HCCLM3均表达人MDA-7 / IL-24的影响,以及正常肝细胞系L02。方法:分别用SG600-IL24和Ad.IL-24感染肝癌细胞和正常肝细胞。通过RT-PCR,ELISA和Western blotting确定MDA-7 / IL-24在感染细胞中的mRNA和蛋白表达。 MTT法用于研究增殖作用。进行了Hoechst染色以及Annexin-V和PI染色,以研究在HCC细胞系和正常肝细胞系中表达的MDA-7 / IL-24基因。流式细胞仪用于分析细胞周期。结果:RT-PCR,ELISA和Western blotting证实,外源MDA-7 / IL-24基因在SG600-IL24感染的细胞中高表达。 MTT和凋亡检测表明,SG600-IL24在肝细胞癌细胞系中的G2 / M期诱导了生长抑制,促进了细胞凋亡,并阻断了癌细胞系,但在正常肝细胞系中却没有。结论:SG600-IL24在体外可选择性诱导肝细胞癌细胞株的生长抑制和凋亡,而在正常肝细胞株L02中则不能。与Ad.IL-24相比,SG600-IL24大大增强了肝癌细胞系的抗肿瘤活性。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2010年第006期|615-621|共7页
  • 作者单位

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

    Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430030, China Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW;

    Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China Zhang H, Gao W and Wang CJ;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:21
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号